Resistance factors in colon cancer tissue and the adjacent normal colon tissue: Glutathione S-transferases α and π, glutathione and aldehyde dehydrogenase

Cancer Letters

Volumn 128, Issue 1, 1998, Pages 105-112

  Hengstler, Jan Georg ^a   Böttger, Thomas ^a   Tanner, Berno ^a   Dietrich, Britta ^a   Henrich, Michael ^a   Knapstein, Paul Georg ^a   Junginger, Th ^a   Oesch, Franz ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Colon cancer tissue; Glutathione S transferases; Resistance factors

Indexed keywords

ALDEHYDE DEHYDROGENASE; GLUTATHIONE; GLUTATHIONE TRANSFERASE;

ADULT; AGED; ARTICLE; CANCER RESISTANCE; CANCER TISSUE; CLINICAL ARTICLE; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION;

ALDEHYDE DEHYDROGENASE; COLON; COLONIC NEOPLASMS; DRUG RESISTANCE, NEOPLASM; GLUTATHIONE; GLUTATHIONE TRANSFERASE; HUMANS;

EID: 0345698972     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00059-7     Document Type: Article

References (37)

1. Andrews P., Velury S., Man X.et al. Cis-diamminedichloroplatinum (II) accumulation in sensitive and resistant human ovarian carcinoma cells. Cancer Res. 48:1988;68-73.
2. Baur G., Wendel A. The activity of the peroxide-metabolizing system in human colon carcinoma. Cancer Res. Clin. Oncol. 97:1980;267-273.
3. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 27:1969;502-522.
4. Butler R.N., Butler W.J., Moraby Z., Fettman M.F., Khoo K.K., Roberts-Thomson I.C. Glutathione concentrations and glutathione S-transferase activity in human colonic neoplasma. J. Gastroenterol. Hepatol. 9:1994;60-63.
5. Cox P.J., Phillips B.J., Thomas P. The enzymatic basis of the selective action of cyclophosphamide. Cancer Res. 35:1975;3755-3761.
6. Cox P.J., Phillips B.J., Thomas P. Studies on the selective action of cyclophosphamide (NSC-26271): inactivation of the hydroxylated metabolite by tissue-soluble enzymes. Cancer Treat. Rep. 60:1976;321-326.
7. Dirven H.A., van Ommen B., van Bladeren P.J. Involvement of human glutathione S-transferase isoenzyme in the conjugation of cyclophosphamide metabolites with glutathione. Cancer Res. 54:1994;6215-6220.
8. Eastman A., Schulte N. Enhanced DNA repair as a mechanism of resistance to cis-diamminedichloroplatinum (II). Biochemistry. 27:1988;4730-4734.
9. Fojo A.T., Ueda K., Slamon D., Poplack D.G., Gottesman M.M., Pastan I. Expression of a multidrug-resistance gene in human tumors and tissues. Proc. Natl. Acad. Sci. USA. 84:1987;265-269.
10. Green J.A., Robertson L.J., Clark A.H. Glutathione S-transferase expression in benign and malignant ovarian tumors. Br. J. Cancer. 68:1993;235-239.
11. Griffith O.W. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridene. Anal. Biochem. 106:1980;207-212.
12. Hamada S., Kamada M., Furumoto H., Hirao T., Aono T. Expression of glutathione S-transferase-pi in human ovarian cancer as an indicator of resistance to chemotherapy. Gynecol. Oncol. 52:1994;313-319.
13. T.C. Hamilton, G. Lai, M. Rothenberg et al., Mechanisms of resistance to cisplatin and alkylating agents, in: R. Ozols (Ed.), Drug Resistance in Cancer Therapy, Kluwer Academic, Boston, MA, 1989, pp. 151-169.
14. Hengstler J.G., Hengst A., Fuchs J., Tanner B., Pohl J., Oesch F. Induction of DNA crosslinks and DNA strand lesions by cyclophosphamide after activation by cytochrome P450 2B1. Mutat. Res. 373:1997;215-223.
15. Hipkins J.H., Struck R.F., Gurtoo H.L. Role of aldehyde dehydrogenase in the metabolism-dependent biological activity of cyclophosphamide. Cancer Res. 41:1981;3571-3583.
16. Hoban P.A., Robson C.N., Davies S.M., Hall A.G., Cattan A.R., Hickson I.D., Harris A.L. Reduced topoisomerase II and elevated alpha class glutathione S-transferase expression in a multidrug resistant CHO cell line highly cross-resistant to mitomycin C. Biochem. Pharmacol. 43:1992;685-689.
17. Howie A.F., Forrester L.M., Glancey M.J., Schlager J.J., Powis G., Beckitt G.J., Hayes J.D., Wolf C.R. Glutathione S-transferase and glutathione peroxidase expression in normal and tumour human tissues. Carcinogenesis. 11:1990;451-458.
18. Johnson S.W., Ozols R.F., Hamilton T.C. Mechanisms of drug resistance in ovarian cancer. Cancer. 71:1993;644-649.
19. Lai G.-M., Ozols R.F., Smyth J.F.et al. Enhanced DNA repair and resistance to cisplatin in human ovarian cancer. Biochem. Pharmacol. 37:1988;4597-4600.
20. Lau D.H., Lewis A.D., Ehsan M.N., Sikie B.I. Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cyanomorpholino doxorubicin. Cancer Res. 51:1991;5181-5187.
21. Masuda H., Ozols R.F., Lai G.-M.et al. Increased DNA repair as a mechanism of acquired resistance to cis-diamminedichloroplatinum (II) in human ovarian cancer cell lines. Cancer Res. 48:1988;5713-5716.
22. Mekhail-Ishak K., Hudson N., Tsao M.S., Batist G. Implications for therapy of drug-metabolizing enzymes in human colon cancer. Cancer Res. 49:1989;4866-4869.
23. A. Meister, Novel drugs that affect glutathione metabolism, in: P.V. Wooley III, K.D. Tew (Eds.), Mechanisms of Drug Resistance in Neoplastic Cells, Academic Press, San Diego, CA, 1988, pp. 99-126.
24. Mistry P., Kellan L.R., Abel G., Sidhar S., Harrop K.R. The relationships between glutathione, glutathione S-transferases and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines. Br. J. Cancer. 64:1991;215-220.
25. Moorghen M., Cairns J., Forrester L.M., Hayes J.D., Hall A., Cattan A.R., Wolf C.R., Harris A.L. Enhanced expression of glutathione S-transferases in colorectal carcinoma compared to non-neoplastic mucosa. Carcinogenesis. 12:1991;113-117.
26. Moron M.D., DePierre J.W., Mannervik B. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim. Biophys. Acta. 582:1979;67-78.
27. Ozols R.F., Louie K., Plowman J.et al. Enhanced melphalan cytotoxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine-sulfoximine depletion of glutathione. Biochem. Pharmacol. 36:1987;147-153.
28. Ozols R.F., O'Dwyer P.F., Hamilton T.C. Clinical reversal of drug resistance in ovarian cancer. Gynecol. Oncol. 51:1993;90-96.
29. R.F. Ozols, P.F. O'Dwyer, T.C. Hamilton, Drug resistance in ovarian cancer, in: M. Markan, W.J. Hoskins (Eds.), Cancer of the Ovary, Raven Press, New York, 1993, pp. 261-276.
30. Peters W.H., Nagengast F.M., Wobbes T. Glutathione S-transferases in normal and cancerous human colon tissue. Carcinogenesis. 10:1989;2371-2374.
31. Redmond S.M., Joncourt F., Buser F., Ziemiecki A., Altermatt H.J., Fey M., Margison G., Cerny T. Assessment of P-glycoprotein, glutathione-based detoxifying enzymes and O6-alkylguanine-DNA alkyltransferase as potential indicators of constitutive drug resistance in human colorectal tumors. Cancer Res. 51:1991;2092-2097.
32. Seidegard J., DePierre J.W., Pero R.W. Hereditary interindividual differences in the glutathione transferase activity towards trans-stilbene oxide in resting human mononuclear leukocytes are due to a particular isoenzyme(s). Carcinogenesis. 6:1985;1211-1216.
33. Sreerama L., Rekha G.K., Sladek N.E. Phenolic antioxidant-induced overexpression of class-3 aldehyde dehydrogenase and oxazophosphorine-specific resistance. Biochem. Pharmacol. 49:1995;669-675.
34. Szarka C.E., Pfeiffer G.R., Hum S.T., Everley L.C., Balshem A.M., Moore D.F., Litwin S., Goosenberg E.B., Frucht H., Engstrom P.F.et al. Glutathione S-transferase activity and glutathione S-transferase expression in subjects with risk for colorectal cancer. Cancer Res. 55:1995;2789-2793.
35. Tanner B., Hengstler J.G., Dietrich B., Henrich M., Steinberg P., Weikel W., Meinert R., Kaina B., Oesch F., Knapstein P.G. Glutathione, glutathione S-transferase α and π and aldehyde dehydrogenase content in relationship to drug resistance in ovarian cancer. Gynecol. Oncol. 65:1997;54-62.
36. Tew K.D. Glutathione-associated enzymes in anticancer drug resistance. Cancer Res. 54:1994;4313-4320.
37. Thiebaut F., Tsurua T., Hamada H., Gottesman M.M., Pastan I., Willingham M.C. Immunohistochemical localization in normal tissues of different epitopes in the multi-drug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein. J. Histochem. Cytochem. 37:1989;159-164.